Diabetes Care, Vol 22, Issue 12 1950-1955, Copyright © 1999 by American Diabetes Association

ARTICLES

Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group

J Komulainen, P Kulmala, K Savola, R Lounamaa, J Ilonen, H Reijonen, M Knip and HK Akerblom
Department of Pediatrics, Kuopio University Hospital, Finland.

OBJECTIVE: To study the characteristics of type 1 diabetes in very young children. RESEARCH DESIGN AND METHODS: Clinical outcome, islet cell antibodies (ICA), insulin autoantibodies (IAA), antibodies against GAD (GADA), IA-2 antibodies (IA-2A), and HLA-DQB1-defined genetic risk were analyzed in 35 children diagnosed with type 1 diabetes before 2 years of age and compared with those in 146 children who were diagnosed between 2.0 and 4.9 years of age and with those in 620 children diagnosed between 5.0 and 14.9 years of age. RESULTS: The youngest age-group had severer metabolic decompensation at clinical onset, and their serum C-peptide levels, compared with those of older children, were lower at the time of diagnosis and during the first 2 years after the diagnosis. The levels of ICA and IAA were highest in children < 2 years of age, but there were no differences in GADA levels among the three age-groups. The youngest age-group had the lowest IA-2A levels. The HLA DQB1*02/*0302 genotype associated with strong genetic susceptibility was more frequent in children diagnosed < 5 years of age, whereas the proportion of children carrying a genotype, which includes protective alleles, was higher among those diagnosed at > or = 5 years of age. CONCLUSIONS: The clinical presentation of type 1 diabetes at a very young age is associated with severe metabolic decompensation, poorly preserved residual beta-cell function, strong humoral autoimmunity against islet cells and insulin, and strong HLA-defined disease susceptibility.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Kaguelidou, C. Alberti, M. Castanet, M.-A. Guitteny, P. Czernichow, J. Leger, and for the French Childhood Graves' Disease Study Gro Predictors of Autoimmune Hyperthyroidism Relapse in Children after Discontinuation of Antithyroid Drug Treatment J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3817 - 3826. [Abstract] [Full Text] [PDF]

				A. Rewers, G. Klingensmith, C. Davis, D. B. Petitti, C. Pihoker, B. Rodriguez, I. D. Schwartz, G. Imperatore, D. Williams, L. M. Dolan, et al. Presence of Diabetic Ketoacidosis at Diagnosis of Diabetes Mellitus in Youth: The Search for Diabetes in Youth Study Pediatrics, May 1, 2008; 121(5): e1258 - e1266. [Abstract] [Full Text] [PDF]

				D. Cody Infant and toddler diabetes Arch. Dis. Child., August 1, 2007; 92(8): 716 - 719. [Full Text] [PDF]

				A. Hekkala, M. Knip, and R. Veijola Ketoacidosis at Diagnosis of Type 1 Diabetes in Children in Northern Finland: Temporal changes over 20 years Diabetes Care, April 1, 2007; 30(4): 861 - 866. [Abstract] [Full Text] [PDF]

				J. Wolfsdorf, N. Glaser, and M. A. Sperling Diabetic Ketoacidosis in Infants, Children, and Adolescents: A consensus statement from the American Diabetes Association Diabetes Care, May 1, 2006; 29(5): 1150 - 1159. [Full Text] [PDF]

				C. Pihoker, L. K. Gilliam, C. S. Hampe, and A. Lernmark Autoantibodies in Diabetes Diabetes, December 1, 2005; 54(suppl_2): S52 - S61. [Abstract] [Full Text] [PDF]

				E. Ortqvist, E. Bjork, M. Wallensteen, J. Ludvigsson, J. Aman, C. Johansson, G. Forsander, F. Lindgren, L. Berglund, M. Bengtsson, et al. Temporary Preservation of {beta}-Cell Function by Diazoxide Treatment in Childhood Type 1 Diabetes Diabetes Care, September 1, 2004; 27(9): 2191 - 2197. [Abstract] [Full Text] [PDF]

				D B Dunger, M A Sperling, C L Acerini, D J Bohn, D Daneman, T P A Danne, N S Glaser, R Hanas, R L Hintz, L L Levitsky, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents Arch. Dis. Child., February 1, 2004; 89(2): 188 - 194. [Abstract] [Full Text]

				D. B. Dunger, M. A. Sperling, C. L. Acerini, D. J. Bohn, D. Daneman, T. P.A. Danne, N. S. Glaser, R. Hanas, R. L. Hintz, L. L. Levitsky, et al. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents Pediatrics, February 1, 2004; 113(2): e133 - 140. [Full Text] [PDF]

				E. H. Hathout, N. Hartwick, O. R. Fagoaga, A. R. Colacino, J. Sharkey, M. Racine, S. Nelsen-Cannarella, and J. W. Mace Clinical, Autoimmune, and HLA Characteristics of Children Diagnosed With Type 1 Diabetes Before 5 Years of Age Pediatrics, April 1, 2003; 111(4): 860 - 863. [Abstract] [Full Text] [PDF]

				M. Knip Can We Predict Type 1 Diabetes in the General Population? Diabetes Care, March 1, 2002; 25(3): 623 - 625. [Full Text] [PDF]

				K. M. Gillespie, E. A.M. Gale, and P. J. Bingley High Familial Risk and Genetic Susceptibility in Early Onset Childhood Diabetes Diabetes, January 1, 2002; 51(1): 210 - 214. [Abstract] [Full Text] [PDF]

				P. Pozzilli and U. Di Mario Autoimmune Diabetes Not Requiring Insulin at Diagnosis (Latent Autoimmune Diabetes of the Adult): Definition, characterization, and potential prevention Diabetes Care, August 1, 2001; 24(8): 1460 - 1467. [Abstract] [Full Text] [PDF]

				P. Kulmala, J. Rahko, K. Savola, P. Vähäsalo, M. Sjöroos, A. Reunanen, J. Ilonen, and M. Knip {beta}-Cell Autoimmunity, Genetic Susceptibility, and Progression to Type 1 Diabetes in Unaffected Schoolchildren Diabetes Care, January 1, 2001; 24(1): 171-a - 173. [Full Text]